Amicus Therapeutics, Inc. (FOLD) Financials

FOLD Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 949.9 million 675.6 million
Sept. 30, 2025 868.8 million 638.4 million
June 30, 2025 815.3 million 611.0 million
March 31, 2025 789.8 million 596.3 million

FOLD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 16.0 million 26.6 million
Sept. 30, 2025 35.3 million 18.1 million
June 30, 2025 -28.9 million 17.6 million
March 31, 2025 7.5 million 25.2 million

FOLD Net Income

No data available :(

FOLD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 293.5 million 433.6 million 41.0 million
Sept. 30, 2025 263.8 million 392.0 million 50.8 million
June 30, 2025 231.0 million 391.3 million 52.0 million
March 31, 2025 250.6 million 390.7 million 52.8 million

FOLD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 314.4 million
Sept. 30, 2025 310.4 million
June 30, 2025 308.3 million
March 31, 2025 307.7 million

FOLD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 299000 23.7 million 117.1 million -
Sept. 30, 2025 382000 23.4 million 90.0 million -
June 30, 2025 2.4 million 60.8 million 84.5 million -
March 31, 2025 212000 27.8 million 91.8 million -

FOLD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 185.2 million 28.4 million
Sept. 30, 2025 169.1 million 21.3 million
June 30, 2025 154.7 million 15.2 million
March 31, 2025 125.2 million 11.7 million

FOLD

Price: $14.49

52 week price:
5.51
14.50

Earnings Per Share: -0.09 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.4 million

Ebitda: -271.1 million

Market Capitalization: 4.5 billion

Links: